8 July, 2024

From XEVMPD to PMS: How ISO IDMP Standards are Revolutionizing Medicinal Product Data Management

The EMA’s move from XEVMPD to ISO IDMP standards marks a major shift for Marketing Authorization Holders (MAHs) in managing medicinal product data. ISO IDMP promises streamlined regulatory, clinical, and safety processes, enhancing data quality, accelerating safety signal detection, and ensuring global consistency.

This article outlines the key benefits of ISO IDMP for pharma, including improved adverse event tracking, coordinated safety efforts, and seamless cross-border data handling—advancing regulatory efficiency and global compliance.

Discover how we can help you

Close Popup

This site uses cookies to personalise and customise your experience. By clicking “I Accept", you consent to cookies in accordance with our privacy policy.

Close Popup
Privacy Settings saved!
Privacy Settings

When you visit any web site, it may store or retrieve information on your browser, mostly in the form of cookies. Control your personal Cookie Services here.

These cookies are necessary for the website to function and cannot be switched off in our systems.

Technical Cookies
In order to use this website we use the following technically required cookies
  • wordpress_test_cookie
  • wordpress_logged_in_
  • wordpress_sec

Cloudflare
In order to use this website we use the following technically required cookies
  • __cfduid

Decline all Services
Save
Accept all Services